Additionally, DMS treatment increased the activation of Nlrc5 and Nlrx1 genes, and had an increasing trend of expression of Nlrp4 , Nlrp5 , Nlrp6 , Nlrp9 genes when compared to T. cruzi -infected cells (Fig. 7B ).
← all excerpts
Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy.
1
—
—